Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study.

Nadeau KJ, Chow K, Alam S, Lindquist K, Campbell S, McFann K, Klingensmith G, Walravens P.

Pediatr Diabetes. 2015 May;16(3):196-203. doi: 10.1111/pedi.12140. Epub 2014 Apr 3.

2.

Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.

Libman IM, Miller KM, DiMeglio LA, Bethin KE, Katz ML, Shah A, Simmons JH, Haller MJ, Raman S, Tamborlane WV, Coffey JK, Saenz AM, Beck RW, Nadeau KJ; T1D Exchange Clinic Network Metformin RCT Study Group.

JAMA. 2015 Dec 1;314(21):2241-50. doi: 10.1001/jama.2015.16174.

3.

Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial.

Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D.

Diabetes Care. 2003 Jan;26(1):138-43.

PMID:
12502670
5.

A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes.

Nwosu BU, Maranda L, Cullen K, Greenman L, Fleshman J, McShea N, Barton BA, Lee MM.

PLoS One. 2015 Sep 14;10(9):e0137525. doi: 10.1371/journal.pone.0137525. eCollection 2015.

7.

Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy.

Barnett AH, Charbonnel B, Li J, Donovan M, Fleming D, Iqbal N.

Clin Drug Investig. 2013 Oct;33(10):707-17. doi: 10.1007/s40261-013-0107-8.

PMID:
23949898
8.

The addition of rosiglitazone to insulin in adolescents with type 1 diabetes and poor glycaemic control: a randomized-controlled trial.

Stone ML, Walker JL, Chisholm D, Craig ME, Donaghue KC, Crock P, Anderson D, Verge CF.

Pediatr Diabetes. 2008 Jul 28;9(4 Pt 1):326-34. doi: 10.1111/j.1399-5448.2008.00383.x. Epub 2008 May 7.

PMID:
18466213
9.

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

Fonseca V, Rosenstock J, Patwardhan R, Salzman A.

JAMA. 2000 Apr 5;283(13):1695-702. Erratum in: JAMA 2000 Sep 20;284(11):1384.

PMID:
10755495
10.

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.

PMID:
16291411
11.

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.

Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

PLoS One. 2008;3(10):e3363. doi: 10.1371/journal.pone.0003363. Epub 2008 Oct 9.

12.

Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.

Horm Metab Res. 2004 Jan;36(1):54-61.

PMID:
14983408
13.
14.

Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria.

Konrad K, Datz N, Engelsberger I, Grulich-Henn J, Hoertenhuber T, Knauth B, Meissner T, Wiegand S, Woelfle J, Holl RW; German/Austrian DPV Initiative.

Pediatr Diabetes. 2015 Nov;16(7):529-37. doi: 10.1111/pedi.12203. Epub 2014 Aug 18.

PMID:
25131985
15.

Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.

Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D.

Clin Ther. 2000 Jun;22(6):709-18.

PMID:
10929918
16.

Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a meta-analysis.

Liu C, Wu D, Zheng X, Li P, Li L.

Diabetes Technol Ther. 2015 Feb;17(2):142-8. doi: 10.1089/dia.2014.0190. Epub 2014 Nov 4.

PMID:
25369141
17.

Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents.

Abdelghaffar S, Attia AM.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006691. doi: 10.1002/14651858.CD006691.pub2. Review.

PMID:
19160294
18.

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

Worsley R, Jane F, Robinson PJ, Bell RJ, Davis SR.

Climacteric. 2015 Apr;18(2):270-7. doi: 10.3109/13697137.2014.954997. Epub 2014 Oct 21.

PMID:
25333776
19.
20.

Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.

Lapolla A, Frison V, Bettio M, Dal Pos M, Rocchini P, Panebianco G, Tadiotto F, Da Tos V, D'Ambrosio M, Marangoni A, Ferrari M, Pianta A, Balzano S, Confortin L, Lamonica M, Marin N, Strazzabosco M, Brun E, Mesturino CA, Simoncini M, Zen F, Bax G, Bonsembiante B, Cardone C, Dal Frà MG, Gallo A, Masin M, Piarulli F, Sartore G, Simioni N.

Clin Ther. 2015 Mar 1;37(3):574-84. doi: 10.1016/j.clinthera.2014.11.015. Epub 2015 Jan 24.

PMID:
25626486

Supplemental Content

Support Center